KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $23,000 | -37.8% | 103,292 | -16.4% | 0.00% | – |
| Q2 2022 | $37,000 | -82.4% | 123,565 | -19.1% | 0.00% | – |
| Q1 2022 | $210,000 | -19.2% | 152,711 | -28.6% | 0.00% | – |
| Q4 2021 | $260,000 | -67.6% | 213,984 | -30.2% | 0.00% | – |
| Q3 2021 | $802,000 | -32.0% | 306,381 | +37.7% | 0.00% | – |
| Q2 2021 | $1,180,000 | +63.7% | 222,562 | +108.1% | 0.00% | – |
| Q1 2021 | $721,000 | -23.8% | 106,949 | -23.3% | 0.00% | – |
| Q4 2020 | $946,000 | +52.1% | 139,447 | +68.0% | 0.00% | – |
| Q3 2020 | $622,000 | -12.5% | 82,995 | +22.8% | 0.00% | – |
| Q2 2020 | $711,000 | +1192.7% | 67,567 | +980.4% | 0.00% | – |
| Q1 2020 | $55,000 | -50.0% | 6,254 | -79.1% | 0.00% | – |
| Q4 2019 | $110,000 | +323.1% | 29,905 | +335.6% | 0.00% | – |
| Q3 2019 | $26,000 | +225.0% | 6,866 | +402.6% | 0.00% | – |
| Q2 2019 | $8,000 | -78.4% | 1,366 | -69.1% | 0.00% | – |
| Q1 2019 | $37,000 | -73.4% | 4,427 | -84.5% | 0.00% | – |
| Q4 2018 | $139,000 | -26.8% | 28,591 | +48.7% | 0.00% | – |
| Q3 2018 | $190,000 | -54.4% | 19,228 | -36.6% | 0.00% | – |
| Q2 2018 | $417,000 | -17.8% | 30,346 | -5.3% | 0.00% | – |
| Q1 2018 | $507,000 | +71.9% | 32,041 | +100.3% | 0.00% | – |
| Q4 2017 | $295,000 | +23.4% | 15,994 | +52.7% | 0.00% | – |
| Q3 2017 | $239,000 | – | 10,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |